Sánchez-Fueyo A - Search Results

1

Persistent hypertransaminasemia as the presenting feature of celiac disease.

González-Abraldes J, Sánchez-Fueyo A, Bessa X, Moitinho E, Feu F, Mas A, Escorsell A, Bruguera M. González-Abraldes J, et al. Am J Gastroenterol. 1999 Apr;94(4):1095-7. doi: 10.1111/j.1572-0241.1999.01021.x. Am J Gastroenterol. 1999. PMID: 10201490

2

Immunosuppression Withdrawal in Liver Transplant Recipients on Sirolimus.

Levitsky J, Burrell BE, Kanaparthi S, Turka LA, Kurian S, Sanchez-Fueyo A, Lozano JJ, Demetris A, Lesniak A, Kirk AD, Stempora L, Yang GY, Mathew JM. Levitsky J, et al. Hepatology. 2020 Aug;72(2):569-583. doi: 10.1002/hep.31036. Epub 2020 Jun 8. Hepatology. 2020. PMID: 31721246 Free PMC article.

3

Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation.

Sánchez-Fueyo A, Whitehouse G, Grageda N, Cramp ME, Lim TY, Romano M, Thirkell S, Lowe K, Fry L, Heward J, Kerr A, Ali J, Fisher C, Lewis G, Hope A, Kodela E, Lyne M, Farzaneh F, Kordasti S, Rebollo-Mesa I, Jose Lozano J, Safinia N, Heaton N, Lechler R, Martínez-Llordella M, Lombardi G. Sánchez-Fueyo A, et al. Am J Transplant. 2020 Apr;20(4):1125-1136. doi: 10.1111/ajt.15700. Epub 2020 Feb 3. Am J Transplant. 2020. PMID: 31715056 Free PMC article. Clinical Trial.

4

The treatment of ascites.

González-Abraldes J, Sánchez-Fueyo A, Arroyo V. González-Abraldes J, et al. Acta Gastroenterol Belg. 1999 Jan-Mar;62(1):41-6; discussion 46-8. Acta Gastroenterol Belg. 1999. PMID: 10333598 Review. No abstract available.

5

Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases.

Giménez-Barcons M, Forns X, Ampurdanés S, Guilera M, Soler M, Soguero C, Sánchez-Fueyo A, Mas A, Bruix J, Sánchez-Tapias JM, Rodés J, Saiz JC. Giménez-Barcons M, et al. J Hepatol. 1999 Jun;30(6):1028-34. doi: 10.1016/s0168-8278(99)80256-6. J Hepatol. 1999. PMID: 10406180

6

Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.

Sánchez-Fueyo A, Rimola A, Grande L, Costa J, Mas A, Navasa M, Cirera I, Sánchez-Tapias JM, Rodés J. Sánchez-Fueyo A, et al. Hepatology. 2000 Feb;31(2):496-501. doi: 10.1002/hep.510310233. Hepatology. 2000. PMID: 10655276

7

Genetic evolution of GB virus C/hepatitis G virus (GBV-C/HGV) under interferon pressure.

Giménez-Barcons M, Sánchez-Fueyo A, Ampurdanés S, Puig-Basagoiti F, Guilera M, Ibáñez A, Clotet B, Martínez MA, Rodés J, Saiz JC, Sánchez-Tapias JM. Giménez-Barcons M, et al. Antiviral Res. 2000 May;46(2):157-70. doi: 10.1016/s0166-3542(00)00079-6. Antiviral Res. 2000. PMID: 10854667

8

Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation.

Segovia R, Sánchez-Fueyo A, Rimola A, Grande L, Bruguera M, Costa J, Soguero C, Uriz J. Segovia R, et al. Liver Transpl. 2001 Feb;7(2):106-12. doi: 10.1053/jlts.2001.21457. Liver Transpl. 2001. PMID: 11172393

9

Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation.

Sánchez-Fueyo A, Giménez-Barcons M, Puig-Basagoiti F, Rimola A, Sánchez-Tapias JM, Sáiz JC, Rodés J. Sánchez-Fueyo A, et al. J Med Virol. 2001 Oct;65(2):266-75. doi: 10.1002/jmv.2029. J Med Virol. 2001. PMID: 11536232

10

Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center.

Forns X, Ampurdanès S, Sanchez-Tapias JM, Guilera M, Sans M, Sánchez-Fueyo A, Quintó L, Joya P, Bruguera M, Rodés J. Forns X, et al. J Hepatol. 2001 Aug;35(2):265-71. doi: 10.1016/s0168-8278(01)00088-5. J Hepatol. 2001. PMID: 11580150

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results